Novavax Inc., a biotechnology company focused on the development and commercialization of next-generation vaccines against serious infectious diseases, today announced preliminary data evaluating the immune response of its vaccine COVID -19, NVX-CoV2373, against the Omicron variant, as well as ...
Chinese biotechnology company Vazyme recently attended Medica 2021 in Germany, one of the world’s largest events for the medical sector, to accelerate the expansion of its international business. At the event, Vazyme showcased its latest 3-in-1 virus testing solutions, ...
AOBiome Therapeutics, a leading clinical-stage biotechnology company focused on inflammation, announced the completion of enrollment in its Phase 2b clinical trial of pruritus (itching) associated with atopic dermatitis. This study builds on previous positive clinical trial results associated with ...
BioSpyder Technologies, Inc. has been awarded a contract by the United States Environmental Protection Agency (EPA) Center for Computational Toxicology and Exposure (CCTE) to perform High Throughput Compatible Gene Expression Profiling for Species of Ecotoxicological Relevance. This is a ...
Hummingbird Bioscience, an innovative clinical-stage biotechnology company focused on developing precision therapies against difficult-to-treat targets, today announced a Trials in Progress poster presentation highlighting the Phase 1 clinical trial design for HMBD-002. HMBD-002 is a unique antibody against VISTA, developed ...
Caris Life Sciences®, a molecular science company developing and delivering technologies to revolutionize healthcare, today announced that the Caris Precision Oncology Alliance™ (POA) and the NCI’s Center for Cancer Research (CCR) will collaborate on precision medicine research initiatives. The ...
During medical appointments, patients expect their bedside doctor to be equally informative and communicative, focusing on the issues at hand. When these appointments take place virtually, the doctor’s camera plays a big role in ensuring that these tendencies are ...
Khanna Vision Institute jumps to the 22nd century. With the introduction of the latest eye technology, patients will be able to be seen by the doctor no matter where he is. For many, traveling to see a top-notch, busy ...
A new multicenter real-world study of PainTEQ‘s LinQ device reflected long-term success and safety in treating sacroiliac (SI) joint dysfunction. The LinQ SI Joint Stabilization System is a minimally invasive procedure that utilizes a single allograft to encourage long-term fusion and help patients ...